SPRY Shareholder Alert: ARS Pharmaceuticals Inc. Securities Class Action Lawsuit - Investors Should Contact Levi & Korsinsky
A securities class action traces ARS Pharmaceuticals' alleged March-to-June 2026 disclosure sequence on CVS Caremark coverage for neffy, ending in a one-day 23.9% collapse in SPRY shares. NEW YORK, Sept. 2, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP reminds purchasers of ARS...
Covered in this story
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.